Skip to main content
Premium Trial:

Request an Annual Quote

Drug Maker Aryx to Use GenomeQuest's Sequence IP Search Service

NEW YORK (GenomeWeb News) — Aryx Therapeutics will use GenomeQuest’s sequence search service for use in intellectual property research related to its retrometabolic drug studies, GenomeQuest said today.
 
GenomeQuest’s software is used by researchers and IP lawyers to evaluate the patentability and competitive landscape for gene sequences.
 
Jeff Anderson, Aryx Therapeutics’ senior manager of IP, said his company looked to GenomeQuest to simplify the process of understanding the patent landscape that surrounds its IP interests in retrometabolic drug design.
  
Financial terms of the agreement were not released.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.